SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India reports Profit after tax of Rs 1992.00 Mln, in the December 2021 quarter

09 Feb 2022 Evaluate
A fair growth of 11.78% in the revenue at Rs. 12243.60 millions was reported in the December 2021 quarter as compared to Rs. 10953.70 millions during year-ago period.A slim rise of 12.45% was recorded in the Net profit for the quarter ended December 2021 to Rs. 1992.00  millions  From Rs. 1771.40 millions.Operating Profit saw a handsome growth to 2878.00 millions from 2568.30 millions in the quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 12243.60 10953.70 11.78 36642.50 32144.90 13.99 43100.20 40931.40 5.30
Other Income 187.40 150.10 24.85 561.60 647.00 -13.20 809.00 1143.90 -29.28
PBIDT 2878.00 2568.30 12.06 8500.60 7806.50 8.89 10023.60 8708.40 15.10
Interest 44.10 43.10 2.32 139.60 135.50 3.03 182.80 85.30 114.30
PBDT 2833.90 2525.20 12.22 8361.00 7671.00 8.99 9840.80 8623.10 14.12
Depreciation 167.40 146.40 14.34 486.70 430.30 13.11 581.30 596.10 -2.48
PBT 2666.50 2378.80 12.09 7874.30 7240.70 8.75 9259.50 8027.00 15.35
TAX 674.50 607.40 11.05 2001.40 1858.50 7.69 2352.60 2097.70 12.15
Deferred Tax -6.10 -14.60 -58.22 -75.50 -48.60 55.35 -37.90 14.70 -357.82
PAT 1992.00 1771.40 12.45 5872.90 5382.20 9.12 6906.90 5929.30 16.49
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 23.51 23.45 0.25 23.20 24.29 -4.47 23.26 21.28 9.31

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×